iPPI-DB

Inhibitors of Protein-Protein Interaction Database

Compound 2061

Identifiers

  • Canonical SMILES:
    Clc1ccc(cc1)[C@@H]1[C@@H](OCC(=O)N1CC1CC1)c1cccc(Cl)c1
  • IUPAC name:
    (5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-(cyclopropylmethyl)morpholin-3-one
  • InChi:
    InChI=1S/C20H19Cl2NO2/c21-16-8-6-14(7-9-16)19-20(15-2-1-3-17(22)10-15)25-12-18(24)23(19)11-13-4-5-13/h1-3,6-10,13,19-20H,4-5,11-12H2/t19-,20+/m1/s1
  • InChiKey:
    USNQYGDSTBFBSK-UXHICEINSA-N

External links


71663526

CHEMBL2347385

External search

Bibliography (1)

Publication Name
Gonzalez-Lopez de Turiso Felix, Sun Daqing, Rew Yosup, Bartberger Michael D., Beck Hilary P., Canon Jude, Chen Ada, Chow David, Correll Tiffany L., Huang Xin, Julian Lisa D., Kayser Frank, Lo Mei-Chu, Long Alexander M., McMinn Dustin, Oliner Jonathan D., Osgood Tao, Powers Jay P., Saiki Anne Y., Schneider Steve, Shaffer Paul, Xiao Shou-Hua, Yakowec Peter, Yan Xuelei, Ye Qiuping, Yu Dongyin, Zhao Xiaoning, Zhou Jing, Medina Julio C., Olson Steven H.. . Rational Design and Binding Mode Duality of MDM2–p53 Inhibitors Journal of Medicinal Chemistry. compound 19

Pharmacological data

Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 0 0 0

Targets

PPI family Best activity Diseases MMoA
MDM2-Like / P53 5.74 cancer Inhibition
Physicochemical filters
Descriptor Lipinski's RO5 Veber Pfizer's 3/75
Compliance
MW 375.08 g/mol
HBA 3
HBD 0
HBA + HBD 3
AlogP 4.63
TPSA 29.54
RB 4
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 1 0 0 0
Pharmacological data
Bibliography Name Target Competition Assay type Assay name Cell line Activity type Activity
10.1021/jm400293z compound 19 MDM2
P56273
P53
P04637
Biochemical assay HTRF pIC50 (half maximal inhibitory concentration, -log10) 5.74
Ta Structure Name Drugbank ID
0.5814 Radafaxine DB11790
0.5402 Saredutant DB06660
0.5319 Osanetant DB04872
0.5301 2,5-dibenzyloxy-3-hydroxy-hexanedioic acid bis-[(2-hydroxy-indan-1-yl)-amide] DB04190
0.5294 N,N-[2,5-O-Dibenzyl-glucaryl]-DI-[1-amino-indan-2-OL] DB01887
0.5087 N,N-[2,5-O-di-2-fluoro-benzyl-glucaryl]-di-[1-amino-indan-2-ol] DB02629
0.5083 Phenmetrazine DB00830
0.5083 Phendimetrazine DB01579
0.5056 Inhibitor BEA388 DB04255
0.5034 (2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid DB03605
0.4910 Rolapitant DB09291
0.4887 Benfluorex DB09022
0.4823 4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide DB08344
0.4797 AZD-9164 DB12115
0.4729 Cloperastine DB09002